Cipro-A 0.30% EYE/EAR Drops contain ciprofloxacin, which is an antibiotic used to treat bacterial infections in the eye or ear, such as corneal ulcers, chronic Suppurative otitis media, external otitis, malignant otitis externa, etc. It is also used to treat inflammatory ear infections in adults and children above 1 year.
However, prolonged use of Cipro-A 0.30% Dropscan led to the growth of other non-susceptible organisms. It's important to use it only for the duration prescribed by your doctor. Pregnant and breastfeeding women should use it with caution and only if the benefits outweigh the risks.
Children below 12 months (1 year) of age, including newborns, should not use Cipro-A 0.30% Drops without a doctor's advice. The most common side effects are redness, itching, irritation, pain, red eye, and double vision. If any of these symptoms worsen, it's important to consult a doctor immediately.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Eye: This combination eye drop is indicated for the treatment of steroid-responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.
Ear: It is indicated for the treatment of ear infections accompanied by inflammation such as otitis externa, otitis media, chronic suppurative otitis media, etc. The combination can also be used for post-operative inflammation of the ear
Frequently reported adverse reactions are transient ocular burning or discomfort. Other reported reactions include stinging, redness, itching, photophobia, conjunctivitis/ keratitis, Periocular/ facial edema, foreign body sensation, blurred vision, tearing, dryness, and eye pain. Elevation of IOP with development of glaucoma, and delayed wound healing may rarely occur.
Cipro-A 0.30% Eye/Ear Drops is an antibiotic, used in the treatment of bacterial eye/ear infections. It relieves the symptoms of the infection by stopping the further growth of the causative microorganisms.
It is not known if alcohol affects Cipro-A 0.30% Drops. However, it is advisable to limit or avoid alcohol as a precautionary measure.
Cipro-A 0.30% Drops should be used during pregnancy only if the potential benefit justifies the potential risk to the developing baby. Consult your doctor before using Cipro-A 0.30% Drops.
Cipro-A 0.30% Drops should be used with caution in breastfeeding mothers due to the lack of safety data in topical use. Consult your doctor before using Cipro-A 0.30% Drops.
Do not drive or use machinery after using Cipro-A 0.30% Drops as the medicine could temporarily blur or affect your vision
Limited information is available about the usage of Cipro-A 0.30% Drops in patients with kidney disease. Please consult your physician.
Limited information is available about the usage of Cipro-A 0.30% Drops in patients with liver disease. Please consult your physician.
Cipro-A 0.30% Drops contains ciprofloxacin, which is an antibiotic with bactericidal activity. It works by inhibiting the activity of the enzyme DNA gyrase in bacteria, which is essential for bacterial DNA synthesis. By doing so, ciprofloxacin prevents the bacteria from replicating and spreading, ultimately leading to their death.
This mechanism of action makes ciprofloxacin an effective treatment for a range of bacterial infections, including external ocular infections of the eye, chronic suppurative otitis media, external otitis, malignant otitis externa, and perioperatively in chronic otitis media. However, it is important to note that ciprofloxacin should only be used to treat bacterial infections and is not effective against viral infections.
Ciprofloxacin is indeed a broad-spectrum antibacterial drug that is administered intravenously in some cases, although it can also be administered orally or topically in the form of eye drops or ear drops. As you mentioned, the bactericidal effect of ciprofloxacin is due to its ability to suppress the activity of two key enzymes in bacteria, topoisomerase II (DNA gyrase) and topoisomerase IV.
Topoisomerases are enzymes that play a critical role in bacterial DNA replication, transcription, repair, and recombination. By inhibiting the activity of these enzymes, ciprofloxacin prevents the bacteria from properly replicating their DNA and carrying out other essential functions necessary for their survival and growth.
Because ciprofloxacin targets multiple aspects of bacterial DNA metabolism, it is effective against a wide range of bacterial species, including both gram-negative and gram-positive bacteria. However, it is important to note that ciprofloxacin is not effective against all types of bacteria, and some strains may be resistant to the drug. Additionally, as with any antibiotic, it is important to use ciprofloxacin judiciously to minimize the development of antibiotic resistance and potential side effects.
Cipro-A 0.30% Drops have various interactions with other drugs. It may increase the plasma concentrations of CYP1A2 substrates such as clozapine, ropinirole, and theophylline. It can enhance the effect of oral anticoagulants like warfarin and glibenclamide, and increase the toxicity of methotrexate. The plasma concentrations may be increased by probenecid.
The medication's absorption is reduced with oral multivitamins and mineral supplements containing divalent or trivalent cations like iron, zinc, and calcium, and antacids containing aluminum, calcium, or magnesium. Concomitant use with class IA antiarrhythmics like quinidine, and procainamide, and class III antiarrhythmics like amiodarone, sotalol, tricyclic antidepressants, macrolides, and antipsychotics may result in additive effects on QT interval prolongation.
The concurrent use of Cipro-A 0.30% Drops with corticosteroids may increase the risk of severe tendon disorders. There is an increased risk of central nervous system stimulation when using nonsteroidal anti-inflammatory drugs. The serum concentrations of phenytoin may be altered. Additionally, there is a potentially fatal risk of marked elevation in serum levels of tizanidine, which is associated with a potentiated hypotensive and sedative effect.
Hypersensitivity to the quinolone antibacterial group or any of the formulation's components.
If the potential benefits outweigh the potential risk during pregnancy, don't use it. It is unknown whether topical ophthalmic administration causes excretion in human milk. Nursing mothers should be treated with caution.
Store below 30° C in a cold, dry, and light-protected location. Keep out of children's reach. Because touching the dropper tip to surfaces can contaminate the solution, avoid doing so. After 30 days from the date of initial opening, do not use.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.